These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24312495)

  • 41. miR-4709-3p Inhibits Cell Proliferation by Downregulating
    Wang Y; Xu S; Wang S; Song Z; Zheng L; Wang G; Sun Y; Bao Y
    DNA Cell Biol; 2021 Jul; 40(7):969-978. PubMed ID: 33956530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
    Xu Z; Wang T
    Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
    Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
    J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells.
    Gholipour N; Ohradanova-Repic A; Ahangari G
    J Cell Biochem; 2018 Aug; 119(8):6408-6417. PubMed ID: 29236292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a.
    Hu CE; Liu YC; Zhang HD; Huang GJ
    Biochem Biophys Res Commun; 2014 Jun; 448(4):437-42. PubMed ID: 24796666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA‑143 targets CD44 to inhibit breast cancer progression and stem cell-like properties.
    Yang Z; Chen D; Nie J; Zhou S; Wang J; Tang Q; Yang X
    Mol Med Rep; 2016 Jun; 13(6):5193-9. PubMed ID: 27121210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
    Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
    Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2.
    Wu T; Song H; Xie D; Hua K; Hu J; Deng Y; Ji C; Fang L
    Biomed Res Int; 2020; 2020():7907269. PubMed ID: 32420372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.
    Lin L; Liu D; Liang H; Xue L; Su C; Liu M
    Int J Clin Exp Pathol; 2015; 8(6):6646-55. PubMed ID: 26261546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
    Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells.
    Liu M; Du Y; Gao J; Liu J; Kong X; Gong Y; Li Z; Wu H; Chen H
    Pancreas; 2013 Oct; 42(7):1169-81. PubMed ID: 24048456
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.
    Sun F; Yu M; Yu J; Liu Z; Zhou X; Liu Y; Ge X; Gao H; Li M; Jiang X; Liu S; Chen X; Guan W
    Cell Death Dis; 2018 May; 9(5):522. PubMed ID: 29743567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.
    Kong X; Li G; Yuan Y; He Y; Wu X; Zhang W; Wu Z; Chen T; Wu W; Lobie PE; Zhu T
    PLoS One; 2012; 7(8):e41523. PubMed ID: 22876288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.
    Zheng L; Meng X; Li X; Zhang Y; Li C; Xiang C; Xing Y; Xia Y; Xi T
    FASEB J; 2018 Feb; 32(2):588-600. PubMed ID: 28939591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B.
    Wang M; Liao J; Tan C; Zhou H; Wang J; Wang K; Li Y; Wu W
    J Cell Mol Med; 2021 Apr; 25(7):3327-3338. PubMed ID: 33635591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.